BRIEF-Sonoma receives U.S. Fda clearance of Loyon skin descaler
March 29 Sonoma Pharmaceuticals Inc
* Sonoma pharmaceuticals receives u.s. Fda clearance of Loyon skin descaler for relief of scaling associated with various dermatoses
* U.S. Commercialization via Sonoma's dermatology division Intraderm Pharmaceuticals' 30-plus-person direct sales team is slated for summer 2017 Source text for Eikon: Further company coverage: